NAMSW · NewAmsterdam Pharma Co N.V. · Documents
Market Cap
$2.45B
Shares
119.54M
Volume · Oct 26
241
Avg daily vol (3M)
2621
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-11-06 | — | |
| 20-F/A | — | 2024-10-28 | 2022-12-31 | |
| 8-K | — | 2024-10-18 | — | |
| 8-K | — | 2024-08-09 | — | |
| 10-Q | — | 2024-08-07 | 2024-06-30 | |
| 8-K | — | 2024-08-07 | — | |
| 8-K | — | 2024-07-29 | — | |
| 8-K | — | 2024-07-18 | 2024-07-16 | |
| S-3 | — | 2024-07-03 | — | |
| 8-K | — | 2024-06-11 | — | |
| 8-K | — | 2024-06-07 | 2024-06-05 | |
| ARS | — | 2024-05-09 | 2023-12-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEF 14A | — | 2024-05-09 | 2024-06-05 | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| PRE 14A | — | 2024-04-29 | 2024-06-05 | |
| 8-K | — | 2024-04-01 | 2024-03-28 | |
| 8-K | — | 2024-03-04 | — | |
| 8-K | — | 2024-02-28 | — | |
| 10-K | — | 2024-02-28 | 2023-12-31 | |
| 8-K | — | 2024-02-15 | 2024-02-13 | |
| 8-K | — | 2024-01-22 | — | |
| 8-K | — | 2024-01-08 | 2024-01-04 | |
| 8-K | — | 2024-01-04 | — | |
| F-3 | — | 2023-12-07 | — | |
| 6-K | — | 2023-11-13 | — | |
| 6-K | — | 2023-10-23 | — | |
| 6-K | — | 2023-09-25 | — | |
| 6-K | — | 2023-09-21 | — | |
| 6-K | — | 2023-08-28 | — | |
| 6-K | — | 2023-08-14 | — | |
| 6-K | — | 2023-08-07 | — | |
| 6-K | — | 2023-08-07 | 2023-06-30 | |
| 6-K | — | 2023-07-26 | — | |
| 6-K | — | 2023-06-21 | — | |
| 6-K | — | 2023-06-12 | 2023-06-09 | |
| 6-K | — | 2023-06-05 | — | |
| 6-K | — | 2023-05-31 | — | |
| 6-K | — | 2023-05-23 | — | |
| 6-K | — | 2023-05-08 | — | |
| 6-K | — | 2023-04-24 | — | |
| 6-K | — | 2023-04-03 | — | |
| 6-K | — | 2023-03-31 | — | |
| 20-F | — | 2023-03-31 | 2022-12-31 | |
| 6-K | — | 2023-03-07 | — | |
| 6-K | — | 2023-03-03 | — | |
| 6-K | — | 2023-02-14 | — | |
| 6-K | — | 2023-02-06 | — | |
| F-1/A | — | 2023-01-17 | — |
Showing 51–100 of 111 filings